Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Liu, Yuan-Ting | en_US |
dc.contributor.author | Hu, Tain-Chang | en_US |
dc.contributor.author | Chang, Cheng-Hsiang | en_US |
dc.contributor.author | Shie, Wen-Shiang | en_US |
dc.contributor.author | Wu, Tung-Kung | en_US |
dc.date.accessioned | 2014-12-08T15:28:12Z | - |
dc.date.available | 2014-12-08T15:28:12Z | - |
dc.date.issued | 2012-10-19 | en_US |
dc.identifier.issn | 1523-7060 | en_US |
dc.identifier.uri | http://dx.doi.org/10.1021/ol302341h | en_US |
dc.identifier.uri | http://hdl.handle.net/11536/20423 | - |
dc.description.abstract | A Saccharomyces cerevisiae oxidosqualene-lanosterol cyclase mutant, ERG7(T384Y/Q450H/V4541), produced parkeol but not lanosterol as the sole end product. Parkeol undergoes downstream metabolism to generate compounds 9 and 10. In vitro incubation of parkeol produced a product profile similar to that of the in vivo experiment. In summary, parkeol undergoes a metabolic pathway similar to that of cycloartenol in yeast but distinct from that of lanosterol in yeast, suggesting that two different metabolic pathways of postoxidosqualene cyclization may exist in S. cerevisiae. | en_US |
dc.language.iso | en_US | en_US |
dc.title | Protein Engineering of Saccharomyces cerevisiae Oxidosqualene-Lanosterol Cyclase into Parkeol Synthase | en_US |
dc.type | Article | en_US |
dc.identifier.doi | 10.1021/ol302341h | en_US |
dc.identifier.journal | ORGANIC LETTERS | en_US |
dc.citation.volume | 14 | en_US |
dc.citation.issue | 20 | en_US |
dc.citation.spage | 5222 | en_US |
dc.citation.epage | 5225 | en_US |
dc.contributor.department | 生物科技學系 | zh_TW |
dc.contributor.department | Department of Biological Science and Technology | en_US |
dc.identifier.wosnumber | WOS:000309951500015 | - |
dc.citation.woscount | 1 | - |
Appears in Collections: | Articles |
Files in This Item:
If it is a zip file, please download the file and unzip it, then open index.html in a browser to view the full text content.